EM Pharma has procured two more stretch wrapping packaging systems from secondary packaging company TrakRap.
The move comes after the consumer healthcare manufacturer achieved significant energy and packaging savings in the past one year by replacing its shrink wrap heat tunnels with TrakRap’s packaging system.
Go deeper with GlobalData
Discover B2B Marketing That Performs
Combine business intelligence and editorial excellence to reach engaged professionals across 36 leading media platforms.
TrakRap’s stretch wrapping packaging system uses bespoke 100% recyclable polymer film to wrap products and bond the pack together.
Developed with ReelVision, TrakRap trays work with the film and use less cartonboard, thereby creating lighter, 100% recyclable retail ready packaging (RRP) for retailers.
Of the two recent TrakRap packaging systems, one features TrakRap`s latest technology that is capable of wrapping one product completely uncollated, removing the need of corrugate trays.
EM Pharma managing director Kevan Abley said: "Secondary packaging for the pharmaceutical sector presents a unique spread of challenges. Our partnership with TrakRap has enabled us to take a holistic view of secondary packaging, looking at the whole process, the film, machinery and tray, rather than each individual element.
US Tariffs are shifting - will you react or anticipate?
Don’t let policy changes catch you off guard. Stay proactive with real-time data and expert analysis.
By GlobalData"We’ve completely eliminated heat from the wrapping process, dramatically reducing our energy usage. The system allows us to be very responsive, and is easily configured to different pack sizes, eliminating film waste."
Since the installation of TrakRap’s packaging systems last year, the company achieved a 96% reduction in energy usage, a 73% reduction in carbon emissions and reduced its usage of cartonboard and film by 45% and 77%, respectively.
Image: TrakRap’s stretch wrapping packaging system uses bespoke 100% recyclable polymer film to wrap products. Photo: courtesy of EM Pharma.
